Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Sell
50
NBIX Quote, Financials, Valuation and Earnings
Last price:
$122.75
Seasonality move
:
6.31%
Day range:
$119.17 - $121.36
52-week range:
$84.23 - $157.98
Dividend yield:
0%
P/E ratio:
41.02x
P/S ratio:
5.19x
P/B ratio:
4.72x
Volume:
970.6K
Avg. volume:
1.9M
1-year change:
-14.72%
Market cap:
$12B
Revenue:
$2.4B
EPS (TTM):
$2.95
Earnings Data
Next earnings date for NBIX
Aug 01
2025
Most recent earnings per share
$0.08
Missed by $1.01
(May 5/2025)
Consensus Estimate
$1.09
(May 5/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
NBIX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/01/2025 | Q2 | $653M | -- | -- | $1.50 | -- |
| 05/05/2025 | Q1 | $561M | $572.6M | $0.08 | $1.09 | -$1.01 |
| 02/06/2025 | Q4 | $629.4M | $627.7M | $1.00 | $1.93 | -$0.93 |
| 10/30/2024 | Q3 | $602.8M | $622.1M | $1.24 | $1.82 | -$0.58 |
| 08/01/2024 | Q2 | $546.6M | $590.2M | $0.63 | $1.53 | -$0.90 |
| 05/01/2024 | Q1 | $512M | $515.3M | $0.42 | $1.29 | -$0.87 |
| 02/07/2024 | Q4 | $518.4M | $515.2M | $1.44 | $1.51 | -$0.07 |
| 10/31/2023 | Q3 | -- | -- | $0.82 | $1.33 | -$0.51 |
| 08/01/2023 | Q2 | -- | -- | $0.95 | $1.12 | -$0.17 |
| 05/03/2023 | Q1 | -- | -- | -$0.79 | $0.74 | -$1.53 |
| 02/06/2023 | Q4 | -- | -- | $0.88 | $1.44 | -$0.56 |
| 11/01/2022 | Q3 | -- | -- | $0.69 | $1.12 | -$0.43 |
| 08/04/2022 | Q2 | -- | -- | -$0.18 | $0.89 | -$1.07 |
| 05/04/2022 | Q1 | -- | -- | $0.14 | $0.59 | -$0.45 |
| 02/11/2022 | Q4 | -- | -- | -$0.08 | $0.88 | -$0.96 |
| 11/01/2021 | Q3 | -- | -- | $0.23 | $0.80 | -$0.57 |
| 08/03/2021 | Q2 | -- | -- | $0.43 | $0.76 | -$0.33 |
| 05/05/2021 | Q1 | -- | -- | $0.33 | $0.72 | -$0.39 |
| 02/04/2021 | Q4 | -- | -- | $3.58 | $0.90 | $2.68 |
| 11/09/2020 | Q3 | -- | -- | -$0.62 | $1.25 | -$1.87 |
| 08/03/2020 | Q2 | -- | -- | $0.81 | $1.02 | -$0.21 |
| 05/06/2020 | Q1 | -- | -- | $0.39 | $0.64 | -$0.25 |
| 02/04/2020 | Q4 | -- | -- | $0.35 | $0.75 | -$0.40 |
| 11/04/2019 | Q3 | -- | -- | $0.56 | $0.64 | -$0.08 |
| 07/29/2019 | Q2 | -- | -- | $0.54 | $0.25 | $0.29 |
| 04/29/2019 | Q1 | -- | -- | -$1.12 | -$0.89 | -$0.23 |
| 02/05/2019 | Q4 | -- | -- | $0.19 | $0.19 | -$0.00 |
| 11/05/2018 | Q3 | -- | -- | $0.52 | $0.49 | $0.03 |
| 07/31/2018 | Q2 | -- | -- | -$0.07 | -$0.18 | $0.11 |
| 04/30/2018 | Q1 | -- | -- | -$0.47 | -$0.30 | -$0.17 |
| 02/13/2018 | Q4 | -- | -- | $0.07 | $0.16 | -$0.09 |
| 11/01/2017 | Q3 | -- | -- | -$0.13 | -$0.53 | $0.40 |
| 08/03/2017 | Q2 | -- | -- | -$0.68 | -$0.65 | -$0.03 |
| 05/09/2017 | Q1 | -- | -- | -$0.90 | -$0.72 | -$0.18 |
| 02/14/2017 | Q4 | -- | -- | -- | -- | -- |
| 11/02/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/03/2016 | Q2 | -- | -- | -- | -- | -- |
| 05/05/2016 | Q1 | -- | -- | -- | -- | -- |
| 02/11/2016 | Q4 | -- | -- | -- | -- | -- |
| 10/29/2015 | Q3 | -- | -- | -- | -- | -- |
| 07/29/2015 | Q2 | -- | -- | -- | -- | -- |
Neurocrine Biosciences Earnings Questions
-
How Much did Neurocrine Biosciences Generate in Revenue Last Quarter?
Neurocrine Biosciences reported $572.6M worth of top line sales in its most recent quarter.
-
Did Neurocrine Biosciences Beat Earnings Last Quarter?
Neurocrine Biosciences announced earnings per share of $0.08 which represents a miss of analyst forecast a $1.09 per share.
-
Is Neurocrine Biosciences Profitable?
Neurocrine Biosciences reported $563.4M that represents $5.50 per share over the last quarter.
-
What is the Analyst Consensus for Neurocrine Biosciences EPS Next Year?
Neurocrine Biosciences's earnings are forecast to grow from $3.29 per share to $6.60 per share next year representing an increase of 85.15%.
-
When is Neurocrine Biosciences's Earnings Date?
Neurocrine Biosciences's next earnings date is August 1, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Mobileye Might Be Wall Street’s Next Big Surprise
The trend to automate vehicles started long ago when adding…
Why Is Rigetti Stock Going Up?
Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 38x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
81
SMLR alert for May 19
Semler Scientific [SMLR] is up 5.85% over the past day.
Sell
25
GLOB alert for May 19
Globant SA [GLOB] is up 4.02% over the past day.
Buy
94
HIMS alert for May 19
Hims & Hers Health [HIMS] is down 3.57% over the past day.
